<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-10-01" modified="2020-10-07" version="234">
<accession>Q07869</accession>
<accession>B0G0X3</accession>
<accession>Q16241</accession>
<accession>Q6I9S0</accession>
<accession>Q92486</accession>
<accession>Q92689</accession>
<accession>Q9Y3N1</accession>
<name>PPARA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Peroxisome proliferator-activated receptor alpha</fullName>
<shortName>PPAR-alpha</shortName>
</recommendedName>
<alternativeName>
<fullName>Nuclear receptor subfamily 1 group C member 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PPARA</name>
<name type="synonym">NR1C1</name>
<name type="synonym">PPAR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Biochemistry" volume="32" first="5598" last="5604">
<title>cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.</title>
<authorList>
<person name="Sher T."/>
<person name="Yi H.F."/>
<person name="McBride O.W."/>
<person name="Gonzales F.J."/>
</authorList>
<dbReference type="PubMed" id="7684926"/>
<dbReference type="DOI" id="10.1021/bi00072a015"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>VARIANT VAL-268</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="J. Steroid Biochem. Mol. Biol." volume="51" first="157" last="166">
<title>Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.</title>
<authorList>
<person name="Mukherjee R."/>
<person name="Jow L."/>
<person name="Noonan D."/>
<person name="McDonnell D.P."/>
</authorList>
<dbReference type="PubMed" id="7981125"/>
<dbReference type="DOI" id="10.1016/0960-0760(94)90089-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Ann. N. Y. Acad. Sci." volume="804" first="252" last="265">
<title>Peroxisome proliferator-activated receptors: structures and function.</title>
<authorList>
<person name="Tugwood J.D."/>
<person name="Aldridge T.C."/>
<person name="Lambe K.G."/>
<person name="Macdonald N."/>
<person name="Woodyatt N.J."/>
</authorList>
<dbReference type="PubMed" id="8993548"/>
<dbReference type="DOI" id="10.1111/j.1749-6632.1996.tb18620.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="FEBS Lett." volume="582" first="2737" last="2744">
<title>DNA-binding profiling of human hormone nuclear receptors via fluorescence correlation spectroscopy in a cell-free system.</title>
<authorList>
<person name="Kobayashi T."/>
<person name="Kodani Y."/>
<person name="Nozawa A."/>
<person name="Endo Y."/>
<person name="Sawasaki T."/>
</authorList>
<dbReference type="PubMed" id="18619963"/>
<dbReference type="DOI" id="10.1016/j.febslet.2008.07.003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2009" name="Immunopharmacol. Immunotoxicol." volume="31" first="459" last="467">
<title>Optimization of an enzyme-linked immunosorbent assay to screen ligand of Peroxisome proliferator-activated receptor alpha.</title>
<authorList>
<person name="Cho M.-C."/>
<person name="Lee S."/>
<person name="Choi H.S."/>
<person name="Yang Y."/>
<person name="Tae Hong J."/>
<person name="Kim S.J."/>
<person name="Yoon D.-Y."/>
</authorList>
<dbReference type="PubMed" id="19263263"/>
<dbReference type="DOI" id="10.1080/08923970902785246"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="submission" date="2008-01" db="EMBL/GenBank/DDBJ databases">
<title>A novel alternatively spliced peroxisome proliferator-activated receptor alpha.</title>
<authorList>
<person name="Jiang Y."/>
<person name="Xie Z."/>
<person name="Liu H."/>
<person name="Liu M."/>
<person name="Liu F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
<title>A genome annotation-driven approach to cloning the human ORFeome.</title>
<authorList>
<person name="Collins J.E."/>
<person name="Wright C.L."/>
<person name="Edwards C.A."/>
<person name="Davis M.P."/>
<person name="Grinham J.A."/>
<person name="Cole C.G."/>
<person name="Goward M.E."/>
<person name="Aguado B."/>
<person name="Mallya M."/>
<person name="Mokrab Y."/>
<person name="Huckle E.J."/>
<person name="Beare D.M."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15461802"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="10">
<citation type="submission" date="2002-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-162</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
<title>The DNA sequence of human chromosome 22.</title>
<authorList>
<person name="Dunham I."/>
<person name="Hunt A.R."/>
<person name="Collins J.E."/>
<person name="Bruskiewich R."/>
<person name="Beare D.M."/>
<person name="Clamp M."/>
<person name="Smink L.J."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Buck D."/>
<person name="Burgess J."/>
<person name="Burrill W.D."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chen Y."/>
<person name="Clark G."/>
<person name="Clegg S.M."/>
<person name="Cobley V.E."/>
<person name="Cole C.G."/>
<person name="Collier R.E."/>
<person name="Connor R."/>
<person name="Conroy D."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Cox A.V."/>
<person name="Davis J."/>
<person name="Dawson E."/>
<person name="Dhami P.D."/>
<person name="Dockree C."/>
<person name="Dodsworth S.J."/>
<person name="Durbin R.M."/>
<person name="Ellington A.G."/>
<person name="Evans K.L."/>
<person name="Fey J.M."/>
<person name="Fleming K."/>
<person name="French L."/>
<person name="Garner A.A."/>
<person name="Gilbert J.G.R."/>
<person name="Goward M.E."/>
<person name="Grafham D.V."/>
<person name="Griffiths M.N.D."/>
<person name="Hall C."/>
<person name="Hall R.E."/>
<person name="Hall-Tamlyn G."/>
<person name="Heathcott R.W."/>
<person name="Ho S."/>
<person name="Holmes S."/>
<person name="Hunt S.E."/>
<person name="Jones M.C."/>
<person name="Kershaw J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.F."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Martyn I.D."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L.H."/>
<person name="Mccann O.T."/>
<person name="Mcclay J."/>
<person name="Mclaren S."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mortimore B.J."/>
<person name="Odell C.N."/>
<person name="Pavitt R."/>
<person name="Pearce A.V."/>
<person name="Pearson D."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S.H."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Ramsey Y."/>
<person name="Rogers L."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Skuce C.D."/>
<person name="Smalley S."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Spragon L."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whiteley M.N."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Williamson H."/>
<person name="Wilmer T.E."/>
<person name="Wilming L."/>
<person name="Wright C.L."/>
<person name="Hubbard T."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Shimizu N."/>
<person name="Minoshima S."/>
<person name="Kawasaki K."/>
<person name="Sasaki T."/>
<person name="Asakawa S."/>
<person name="Kudoh J."/>
<person name="Shintani A."/>
<person name="Shibuya K."/>
<person name="Yoshizaki Y."/>
<person name="Aoki N."/>
<person name="Mitsuyama S."/>
<person name="Roe B.A."/>
<person name="Chen F."/>
<person name="Chu L."/>
<person name="Crabtree J."/>
<person name="Deschamps S."/>
<person name="Do A."/>
<person name="Do T."/>
<person name="Dorman A."/>
<person name="Fang F."/>
<person name="Fu Y."/>
<person name="Hu P."/>
<person name="Hua A."/>
<person name="Kenton S."/>
<person name="Lai H."/>
<person name="Lao H.I."/>
<person name="Lewis J."/>
<person name="Lewis S."/>
<person name="Lin S.-P."/>
<person name="Loh P."/>
<person name="Malaj E."/>
<person name="Nguyen T."/>
<person name="Pan H."/>
<person name="Phan S."/>
<person name="Qi S."/>
<person name="Qian Y."/>
<person name="Ray L."/>
<person name="Ren Q."/>
<person name="Shaull S."/>
<person name="Sloan D."/>
<person name="Song L."/>
<person name="Wang Q."/>
<person name="Wang Y."/>
<person name="Wang Z."/>
<person name="White J."/>
<person name="Willingham D."/>
<person name="Wu H."/>
<person name="Yao Z."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Chissoe S."/>
<person name="Murray J."/>
<person name="Miller N."/>
<person name="Minx P."/>
<person name="Fulton R."/>
<person name="Johnson D."/>
<person name="Bemis G."/>
<person name="Bentley D."/>
<person name="Bradshaw H."/>
<person name="Bourne S."/>
<person name="Cordes M."/>
<person name="Du Z."/>
<person name="Fulton L."/>
<person name="Goela D."/>
<person name="Graves T."/>
<person name="Hawkins J."/>
<person name="Hinds K."/>
<person name="Kemp K."/>
<person name="Latreille P."/>
<person name="Layman D."/>
<person name="Ozersky P."/>
<person name="Rohlfing T."/>
<person name="Scheet P."/>
<person name="Walker C."/>
<person name="Wamsley A."/>
<person name="Wohldmann P."/>
<person name="Pepin K."/>
<person name="Nelson J."/>
<person name="Korf I."/>
<person name="Bedell J.A."/>
<person name="Hillier L.W."/>
<person name="Mardis E."/>
<person name="Waterston R."/>
<person name="Wilson R."/>
<person name="Emanuel B.S."/>
<person name="Shaikh T."/>
<person name="Kurahashi H."/>
<person name="Saitta S."/>
<person name="Budarf M.L."/>
<person name="McDermid H.E."/>
<person name="Johnson A."/>
<person name="Wong A.C.C."/>
<person name="Morrow B.E."/>
<person name="Edelmann L."/>
<person name="Kim U.J."/>
<person name="Shizuya H."/>
<person name="Simon M.I."/>
<person name="Dumanski J.P."/>
<person name="Peyrard M."/>
<person name="Kedra D."/>
<person name="Seroussi E."/>
<person name="Fransson I."/>
<person name="Tapia I."/>
<person name="Bruder C.E."/>
<person name="O'Brien K.P."/>
<person name="Wilkinson P."/>
<person name="Bodenteich A."/>
<person name="Hartman K."/>
<person name="Hu X."/>
<person name="Khan A.S."/>
<person name="Lane L."/>
<person name="Tilahun Y."/>
<person name="Wright H."/>
</authorList>
<dbReference type="PubMed" id="10591208"/>
<dbReference type="DOI" id="10.1038/990031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="18117" last="18122">
<title>Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.</title>
<authorList>
<person name="Juge-Aubry C.E."/>
<person name="Gorla-Bajszczak A."/>
<person name="Pernin A."/>
<person name="Lemberger T."/>
<person name="Wahli W."/>
<person name="Burger A.G."/>
<person name="Meier C.A."/>
</authorList>
<dbReference type="PubMed" id="7629123"/>
<dbReference type="DOI" id="10.1074/jbc.270.30.18117"/>
</citation>
<scope>HETERODIMERIZATION WITH RXRA</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-122; LEU-422 AND LEU-433</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="8479" last="8484">
<title>RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.</title>
<authorList>
<person name="Li H."/>
<person name="Gomes P.J."/>
<person name="Chen J.D."/>
</authorList>
<dbReference type="PubMed" id="9238002"/>
<dbReference type="DOI" id="10.1073/pnas.94.16.8479"/>
</citation>
<scope>INTERACTION WITH NCOA3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="10948" last="10957">
<title>Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4.</title>
<authorList>
<person name="Yan Z.H."/>
<person name="Karam W.G."/>
<person name="Staudinger J.L."/>
<person name="Medvedev A."/>
<person name="Ghanayem B.I."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="9556573"/>
<dbReference type="DOI" id="10.1074/jbc.273.18.10948"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Mol. Cell. Endocrinol." volume="147" first="37" last="47">
<title>Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.</title>
<authorList>
<person name="Gorla-Bajszczak A."/>
<person name="Juge-Aubry C."/>
<person name="Pernin A."/>
<person name="Burger A.G."/>
<person name="Meier C.A."/>
</authorList>
<dbReference type="PubMed" id="10195690"/>
<dbReference type="DOI" id="10.1016/s0303-7207(98)00217-2"/>
</citation>
<scope>HETERODIMERIZATION WITH RXRA</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-304; LEU-370; LEU-391 AND ALA-431</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="5308" last="5317">
<title>Cloning and characterization of RAP250, a nuclear receptor coactivator.</title>
<authorList>
<person name="Caira F."/>
<person name="Antonson P."/>
<person name="Pelto-Huikko M."/>
<person name="Treuter E."/>
<person name="Gustafsson J.-A."/>
</authorList>
<dbReference type="PubMed" id="10681503"/>
<dbReference type="DOI" id="10.1074/jbc.275.8.5308"/>
</citation>
<scope>INTERACTION WITH NCOA6</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Hepatology" volume="35" first="937" last="946">
<title>Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity.</title>
<authorList>
<person name="Tsutsumi T."/>
<person name="Suzuki T."/>
<person name="Shimoike T."/>
<person name="Suzuki R."/>
<person name="Moriya K."/>
<person name="Shintani Y."/>
<person name="Fujie H."/>
<person name="Matsuura Y."/>
<person name="Koike K."/>
<person name="Miyamura T."/>
</authorList>
<dbReference type="PubMed" id="11915042"/>
<dbReference type="DOI" id="10.1053/jhep.2002.32470"/>
</citation>
<scope>HETERODIMERIZATION WITH RXRA</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Nature" volume="425" first="90" last="93">
<title>Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.</title>
<authorList>
<person name="Fu J."/>
<person name="Gaetani S."/>
<person name="Oveisi F."/>
<person name="Lo Verme J."/>
<person name="Serrano A."/>
<person name="Rodriguez De Fonseca F."/>
<person name="Rosengarth A."/>
<person name="Luecke H."/>
<person name="Di Giacomo B."/>
<person name="Tarzia G."/>
<person name="Piomelli D."/>
</authorList>
<dbReference type="PubMed" id="12955147"/>
<dbReference type="DOI" id="10.1038/nature01921"/>
</citation>
<scope>IDENTIFICATION AS RECEPTOR FOR OLEYLETHANOLAMIDE</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="1354" last="1363">
<title>Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma}.</title>
<authorList>
<person name="Park U.H."/>
<person name="Yoon S.K."/>
<person name="Park T."/>
<person name="Kim E.J."/>
<person name="Um S.J."/>
</authorList>
<dbReference type="PubMed" id="21047783"/>
<dbReference type="DOI" id="10.1074/jbc.m110.177816"/>
</citation>
<scope>INTERACTION WITH ASXL1 AND ASXL2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="4552" last="4561">
<title>SIRT4 represses peroxisome proliferator-activated receptor alpha activity to suppress hepatic fat oxidation.</title>
<authorList>
<person name="Laurent G."/>
<person name="de Boer V.C."/>
<person name="Finley L.W."/>
<person name="Sweeney M."/>
<person name="Lu H."/>
<person name="Schug T.T."/>
<person name="Cen Y."/>
<person name="Jeong S.M."/>
<person name="Li X."/>
<person name="Sauve A.A."/>
<person name="Haigis M.C."/>
</authorList>
<dbReference type="PubMed" id="24043310"/>
<dbReference type="DOI" id="10.1128/mcb.00087-13"/>
</citation>
<scope>INTERACTION WITH SIRT1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2017" name="Proc. Natl. Acad. Sci. U.S.A." volume="114" first="2072" last="2077">
<title>MicroRNA-10a is crucial for endothelial response to different flow patterns via interaction of retinoid acid receptors and histone deacetylases.</title>
<authorList>
<person name="Lee D.Y."/>
<person name="Lin T.E."/>
<person name="Lee C.I."/>
<person name="Zhou J."/>
<person name="Huang Y.H."/>
<person name="Lee P.L."/>
<person name="Shih Y.T."/>
<person name="Chien S."/>
<person name="Chiu J.J."/>
</authorList>
<dbReference type="PubMed" id="28167758"/>
<dbReference type="DOI" id="10.1073/pnas.1621425114"/>
</citation>
<scope>REPRESSION BY AGING</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="13919" last="13924">
<title>Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.</title>
<authorList>
<person name="Xu H.E."/>
<person name="Lambert M.H."/>
<person name="Montana V.G."/>
<person name="Plunket K.D."/>
<person name="Moore L.B."/>
<person name="Collins J.L."/>
<person name="Oplinger J.A."/>
<person name="Kliewer S.A."/>
<person name="Gampe R.T. Jr."/>
<person name="McKee D.D."/>
<person name="Moore J.T."/>
<person name="Willson T.M."/>
</authorList>
<dbReference type="PubMed" id="11698662"/>
<dbReference type="DOI" id="10.1073/pnas.241410198"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 192-468 IN COMPLEX WITH SYNTHETIC AGONIST</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="Structure" volume="9" first="699" last="706">
<title>Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.</title>
<authorList>
<person name="Cronet P."/>
<person name="Petersen J.F.W."/>
<person name="Folmer R."/>
<person name="Blomberg N."/>
<person name="Sjoeblom K."/>
<person name="Karlsson U."/>
<person name="Lindstedt E.-L."/>
<person name="Bamberg K."/>
</authorList>
<dbReference type="PubMed" id="11587644"/>
<dbReference type="DOI" id="10.1016/s0969-2126(01)00634-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.24 ANGSTROMS) OF 196-468 IN COMPLEX WITH SYNTHETIC AGONIST</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Nature" volume="415" first="813" last="817">
<title>Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.</title>
<authorList>
<person name="Xu H.E."/>
<person name="Stanley T.B."/>
<person name="Montana V.G."/>
<person name="Lambert M.H."/>
<person name="Shearer B.G."/>
<person name="Cobb J.E."/>
<person name="McKee D.D."/>
<person name="Galardi C.M."/>
<person name="Plunket K.D."/>
<person name="Nolte R.T."/>
<person name="Parks D.J."/>
<person name="Moore J.T."/>
<person name="Kliewer S.A."/>
<person name="Willson T.M."/>
<person name="Stimmel J.B."/>
</authorList>
<dbReference type="PubMed" id="11845213"/>
<dbReference type="DOI" id="10.1038/415813a"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 200-468 IN COMPLEX WITH SYNTHETIC AGONIST</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="Bioorg. Med. Chem. Lett." volume="17" first="937" last="941">
<title>Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.</title>
<authorList>
<person name="Oon Han H."/>
<person name="Kim S.H."/>
<person name="Kim K.-H."/>
<person name="Hur G.-C."/>
<person name="Joo Yim H."/>
<person name="Chung H.-K."/>
<person name="Ho Woo S."/>
<person name="Dong Koo K."/>
<person name="Lee C.-S."/>
<person name="Sung Koh J."/>
<person name="Kim G.T."/>
</authorList>
<dbReference type="PubMed" id="17157019"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2006.11.050"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 199-468 IN COMPLEX WITH SYNTHETIC AGONIST</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Med. Chem." volume="50" first="685" last="695">
<title>Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents.</title>
<authorList>
<person name="Sierra M.L."/>
<person name="Beneton V."/>
<person name="Boullay A.-B."/>
<person name="Boyer T."/>
<person name="Brewster A.G."/>
<person name="Donche F."/>
<person name="Forest M.-C."/>
<person name="Fouchet M.-H."/>
<person name="Gellibert F.J."/>
<person name="Grillot D.A."/>
<person name="Lambert M.H."/>
<person name="Laroze A."/>
<person name="Le Grumelec C."/>
<person name="Linget J.M."/>
<person name="Montana V.G."/>
<person name="Nguyen V.-L."/>
<person name="Nicodeme E."/>
<person name="Patel V."/>
<person name="Penfornis A."/>
<person name="Pineau O."/>
<person name="Pohin D."/>
<person name="Potvain F."/>
<person name="Poulain G."/>
<person name="Ruault C.B."/>
<person name="Saunders M."/>
<person name="Toum J."/>
<person name="Xu H.E."/>
<person name="Xu R.X."/>
<person name="Pianetti P.M."/>
</authorList>
<dbReference type="PubMed" id="17243659"/>
<dbReference type="DOI" id="10.1021/jm058056x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 202-468 IN COMPLEX WITH SYNTHETIC AGONIST</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Acta Crystallogr. D" volume="65" first="786" last="795">
<title>Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures.</title>
<authorList>
<person name="Oyama T."/>
<person name="Toyota K."/>
<person name="Waku T."/>
<person name="Hirakawa Y."/>
<person name="Nagasawa N."/>
<person name="Kasuga J.I."/>
<person name="Hashimoto Y."/>
<person name="Miyachi H."/>
<person name="Morikawa K."/>
</authorList>
<dbReference type="PubMed" id="19622862"/>
<dbReference type="DOI" id="10.1107/s0907444909015935"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 200-468 IN COMPLEX WITH THE SYNTHETIC AGONIST TIPP-703</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Bioorg. Med. Chem. Lett." volume="19" first="2468" last="2473">
<title>Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes.</title>
<authorList>
<person name="Benardeau A."/>
<person name="Benz J."/>
<person name="Binggeli A."/>
<person name="Blum D."/>
<person name="Boehringer M."/>
<person name="Grether U."/>
<person name="Hilpert H."/>
<person name="Kuhn B."/>
<person name="Maerki H.P."/>
<person name="Meyer M."/>
<person name="Puentener K."/>
<person name="Raab S."/>
<person name="Ruf A."/>
<person name="Schlatter D."/>
<person name="Mohr P."/>
</authorList>
<dbReference type="PubMed" id="19349176"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2009.03.036"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 199-468 IN COMPLEX WITH ALEGLITAZAR</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="262" last="267">
<title>Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.</title>
<authorList>
<person name="Artis D.R."/>
<person name="Lin J.J."/>
<person name="Zhang C."/>
<person name="Wang W."/>
<person name="Mehra U."/>
<person name="Perreault M."/>
<person name="Erbe D."/>
<person name="Krupka H.I."/>
<person name="England B.P."/>
<person name="Arnold J."/>
<person name="Plotnikov A.N."/>
<person name="Marimuthu A."/>
<person name="Nguyen H."/>
<person name="Will S."/>
<person name="Signaevsky M."/>
<person name="Kral J."/>
<person name="Cantwell J."/>
<person name="Settachatgull C."/>
<person name="Yan D.S."/>
<person name="Fong D."/>
<person name="Oh A."/>
<person name="Shi S."/>
<person name="Womack P."/>
<person name="Powell B."/>
<person name="Habets G."/>
<person name="West B.L."/>
<person name="Zhang K.Y.J."/>
<person name="Milburn M.V."/>
<person name="Vlasuk G.P."/>
<person name="Hirth K.P."/>
<person name="Nolop K."/>
<person name="Bollag G."/>
<person name="Ibrahim P.N."/>
<person name="Tobin J.F."/>
</authorList>
<dbReference type="PubMed" id="19116277"/>
<dbReference type="DOI" id="10.1073/pnas.0811325106"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 199-468 IN COMPLEX WITH INDEGLITAZAR</scope>
</reference>
<comment type="function">
<text evidence="10 21 23 24 28">Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2.</text>
</comment>
<comment type="subunit">
<text evidence="6 7 11 12 13 14 15 16 17 18 19 20 21 27">Heterodimer; with RXRA. This heterodimerization is required for DNA binding and transactivation activity. Interacts with NCOA3 coactivator. Interacts with CITED2; the interaction stimulates its transcriptional activity. Also interacts with PPARBP in vitro. Interacts with AKAP13, LPIN1, PRDM16 and coactivator NCOA6. Interacts with ASXL1 and ASXL2. Interacts with PER2. Interacts with SIRT1; the interaction seems to be modulated by NAD(+) levels (PubMed:24043310). Interacts with CRY1 and CRY2 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78615">
<id>Q07869</id>
</interactant>
<interactant intactId="EBI-960730">
<id>Q3L8U1-3</id>
<label>CHD9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78615">
<id>Q07869</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78615">
<id>Q07869</id>
</interactant>
<interactant intactId="EBI-347233">
<id>O75376</id>
<label>NCOR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78615">
<id>Q07869</id>
</interactant>
<interactant intactId="EBI-781356">
<id>Q13133</id>
<label>NR1H3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-21458428">
<id>Q07869-1</id>
</interactant>
<interactant intactId="EBI-21458417">
<id>P55055-1</id>
<label>NR1H2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-21458428">
<id>Q07869-1</id>
</interactant>
<interactant intactId="EBI-781356">
<id>Q13133</id>
<label>NR1H3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q07869-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q07869-2</id>
<name>2</name>
<sequence type="described" ref="VSP_047571 VSP_047572"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="22 25 26">Skeletal muscle, liver, heart and kidney. Expressed in monocytes (PubMed:28167758).</text>
</comment>
<comment type="induction">
<text evidence="22">Down-regulated by aging.</text>
</comment>
<comment type="similarity">
<text evidence="31">Belongs to the nuclear hormone receptor family. NR1 subfamily.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Peroxisome_proliferator-activated_receptor"/>
<text>Peroxisome proliferator-activated receptor entry</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ppara/"/>
</comment>
<dbReference type="EMBL" id="L02932">
<property type="protein sequence ID" value="AAA36468.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S74349">
<property type="protein sequence ID" value="AAB32649.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y07619">
<property type="protein sequence ID" value="CAA68898.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB307690">
<property type="protein sequence ID" value="BAH02281.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU650667">
<property type="protein sequence ID" value="ACD12656.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU395809">
<property type="protein sequence ID" value="ABY73535.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR456547">
<property type="protein sequence ID" value="CAG30433.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289821">
<property type="protein sequence ID" value="BAF82510.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR457435">
<property type="protein sequence ID" value="CAG33716.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY206718">
<property type="protein sequence ID" value="AAO13489.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049856">
<property type="protein sequence ID" value="CAI22450.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL078611">
<property type="protein sequence ID" value="CAI22450.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z94161">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471138">
<property type="protein sequence ID" value="EAW73402.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33669.1">
<molecule id="Q07869-1"/>
</dbReference>
<dbReference type="PIR" id="A49289">
<property type="entry name" value="A49289"/>
</dbReference>
<dbReference type="PIR" id="I56603">
<property type="entry name" value="I56603"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001001928.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="NM_001001928.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005027.2">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="NM_005036.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005261712.1">
<property type="nucleotide sequence ID" value="XM_005261655.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005261713.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="XM_005261656.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006724332.1">
<property type="nucleotide sequence ID" value="XM_006724269.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006724333.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="XM_006724270.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528541.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="XM_011530239.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528542.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="XM_011530240.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528543.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="XM_011530241.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528544.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="XM_011530242.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528545.1">
<molecule id="Q07869-1"/>
<property type="nucleotide sequence ID" value="XM_011530243.2"/>
</dbReference>
<dbReference type="PDB" id="1I7G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=196-468"/>
</dbReference>
<dbReference type="PDB" id="1K7L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/C/E/G=192-468"/>
</dbReference>
<dbReference type="PDB" id="1KKQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D=200-468"/>
</dbReference>
<dbReference type="PDB" id="2NPA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/C=199-468"/>
</dbReference>
<dbReference type="PDB" id="2P54">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=202-468"/>
</dbReference>
<dbReference type="PDB" id="2REW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=196-468"/>
</dbReference>
<dbReference type="PDB" id="2ZNN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=200-468"/>
</dbReference>
<dbReference type="PDB" id="3ET1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=199-468"/>
</dbReference>
<dbReference type="PDB" id="3FEI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=202-468"/>
</dbReference>
<dbReference type="PDB" id="3G8I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=199-468"/>
</dbReference>
<dbReference type="PDB" id="3KDT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=196-468"/>
</dbReference>
<dbReference type="PDB" id="3KDU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A/B=196-468"/>
</dbReference>
<dbReference type="PDB" id="3SP6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.21"/>
<property type="chains" value="A=196-468"/>
</dbReference>
<dbReference type="PDB" id="3VI8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=200-468"/>
</dbReference>
<dbReference type="PDB" id="4BCR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=195-468"/>
</dbReference>
<dbReference type="PDB" id="4CI4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=195-468"/>
</dbReference>
<dbReference type="PDB" id="5AZT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.45"/>
<property type="chains" value="A/B=201-468"/>
</dbReference>
<dbReference type="PDB" id="5HYK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=200-468"/>
</dbReference>
<dbReference type="PDB" id="6KXX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=200-468"/>
</dbReference>
<dbReference type="PDB" id="6KXY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=200-468"/>
</dbReference>
<dbReference type="PDB" id="6L96">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=194-468"/>
</dbReference>
<dbReference type="PDBsum" id="1I7G"/>
<dbReference type="PDBsum" id="1K7L"/>
<dbReference type="PDBsum" id="1KKQ"/>
<dbReference type="PDBsum" id="2NPA"/>
<dbReference type="PDBsum" id="2P54"/>
<dbReference type="PDBsum" id="2REW"/>
<dbReference type="PDBsum" id="2ZNN"/>
<dbReference type="PDBsum" id="3ET1"/>
<dbReference type="PDBsum" id="3FEI"/>
<dbReference type="PDBsum" id="3G8I"/>
<dbReference type="PDBsum" id="3KDT"/>
<dbReference type="PDBsum" id="3KDU"/>
<dbReference type="PDBsum" id="3SP6"/>
<dbReference type="PDBsum" id="3VI8"/>
<dbReference type="PDBsum" id="4BCR"/>
<dbReference type="PDBsum" id="4CI4"/>
<dbReference type="PDBsum" id="5AZT"/>
<dbReference type="PDBsum" id="5HYK"/>
<dbReference type="PDBsum" id="6KXX"/>
<dbReference type="PDBsum" id="6KXY"/>
<dbReference type="PDBsum" id="6L96"/>
<dbReference type="SMR" id="Q07869"/>
<dbReference type="BioGRID" id="111461">
<property type="interactions" value="70"/>
</dbReference>
<dbReference type="DIP" id="DIP-241N"/>
<dbReference type="IntAct" id="Q07869">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="MINT" id="Q07869"/>
<dbReference type="STRING" id="9606.ENSP00000385523"/>
<dbReference type="BindingDB" id="Q07869"/>
<dbReference type="ChEMBL" id="CHEMBL239"/>
<dbReference type="DrugBank" id="DB08915">
<property type="generic name" value="Aleglitazar"/>
</dbReference>
<dbReference type="DrugBank" id="DB00132">
<property type="generic name" value="alpha-Linolenic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01118">
<property type="generic name" value="Amiodarone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04557">
<property type="generic name" value="Arachidonic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01393">
<property type="generic name" value="Bezafibrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB04519">
<property type="generic name" value="Caprylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB05416">
<property type="generic name" value="Cardarine"/>
</dbReference>
<dbReference type="DrugBank" id="DB09064">
<property type="generic name" value="Ciprofibrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09006">
<property type="generic name" value="Clinofibrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00636">
<property type="generic name" value="Clofibrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09213">
<property type="generic name" value="Dexibuprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB03756">
<property type="generic name" value="Doconexent"/>
</dbReference>
<dbReference type="DrugBank" id="DB05187">
<property type="generic name" value="Elafibranor"/>
</dbReference>
<dbReference type="DrugBank" id="DB06521">
<property type="generic name" value="Ertiprotafib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01039">
<property type="generic name" value="Fenofibrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13873">
<property type="generic name" value="Fenofibric acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00573">
<property type="generic name" value="Fenoprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB13961">
<property type="generic name" value="Fish oil"/>
</dbReference>
<dbReference type="DrugBank" id="DB02266">
<property type="generic name" value="Flufenamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01241">
<property type="generic name" value="Gemfibrozil"/>
</dbReference>
<dbReference type="DrugBank" id="DB07215">
<property type="generic name" value="GW-590735"/>
</dbReference>
<dbReference type="DrugBank" id="DB01050">
<property type="generic name" value="Ibuprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00159">
<property type="generic name" value="Icosapent"/>
</dbReference>
<dbReference type="DrugBank" id="DB07724">
<property type="generic name" value="Indeglitazar"/>
</dbReference>
<dbReference type="DrugBank" id="DB00328">
<property type="generic name" value="Indomethacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB12007">
<property type="generic name" value="Isoflavone"/>
</dbReference>
<dbReference type="DrugBank" id="DB03017">
<property type="generic name" value="Lauric acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB12961">
<property type="generic name" value="Leukotriene B4"/>
</dbReference>
<dbReference type="DrugBank" id="DB06510">
<property type="generic name" value="Muraglitazar"/>
</dbReference>
<dbReference type="DrugBank" id="DB08231">
<property type="generic name" value="Myristic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB11605">
<property type="generic name" value="Myrrh"/>
</dbReference>
<dbReference type="DrugBank" id="DB01890">
<property type="generic name" value="N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB04224">
<property type="generic name" value="Oleic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB11133">
<property type="generic name" value="Omega-3 fatty acids"/>
</dbReference>
<dbReference type="DrugBank" id="DB03796">
<property type="generic name" value="Palmitic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB02746">
<property type="generic name" value="Phthalic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB06533">
<property type="generic name" value="Ragaglitazar"/>
</dbReference>
<dbReference type="DrugBank" id="DB04971">
<property type="generic name" value="Reglitazar"/>
</dbReference>
<dbReference type="DrugBank" id="DB02709">
<property type="generic name" value="Resveratrol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00412">
<property type="generic name" value="Rosiglitazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09422">
<property type="generic name" value="Soybean oil"/>
</dbReference>
<dbReference type="DrugBank" id="DB03193">
<property type="generic name" value="Stearic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB06536">
<property type="generic name" value="Tesaglitazar"/>
</dbReference>
<dbReference type="DrugBank" id="DB00197">
<property type="generic name" value="Troglitazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00313">
<property type="generic name" value="Valproic acid"/>
</dbReference>
<dbReference type="DrugCentral" id="Q07869"/>
<dbReference type="GuidetoPHARMACOLOGY" id="593"/>
<dbReference type="SwissLipids" id="SLP:000001644"/>
<dbReference type="iPTMnet" id="Q07869"/>
<dbReference type="PhosphoSitePlus" id="Q07869"/>
<dbReference type="BioMuta" id="PPARA"/>
<dbReference type="DMDM" id="3041727"/>
<dbReference type="MassIVE" id="Q07869"/>
<dbReference type="PaxDb" id="Q07869"/>
<dbReference type="PeptideAtlas" id="Q07869"/>
<dbReference type="PRIDE" id="Q07869"/>
<dbReference type="ProteomicsDB" id="58553">
<molecule id="Q07869-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="13823">
<property type="antibodies" value="763 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5465"/>
<dbReference type="Ensembl" id="ENST00000262735">
<molecule id="Q07869-1"/>
<property type="protein sequence ID" value="ENSP00000262735"/>
<property type="gene ID" value="ENSG00000186951"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402126">
<molecule id="Q07869-1"/>
<property type="protein sequence ID" value="ENSP00000385246"/>
<property type="gene ID" value="ENSG00000186951"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000407236">
<molecule id="Q07869-1"/>
<property type="protein sequence ID" value="ENSP00000385523"/>
<property type="gene ID" value="ENSG00000186951"/>
</dbReference>
<dbReference type="GeneID" id="5465"/>
<dbReference type="KEGG" id="hsa:5465"/>
<dbReference type="UCSC" id="uc003bgx.1">
<molecule id="Q07869-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5465"/>
<dbReference type="DisGeNET" id="5465"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000186951.16"/>
<dbReference type="GeneCards" id="PPARA"/>
<dbReference type="HGNC" id="HGNC:9232">
<property type="gene designation" value="PPARA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000186951">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="170998">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q07869"/>
<dbReference type="OpenTargets" id="ENSG00000186951"/>
<dbReference type="PharmGKB" id="PA280"/>
<dbReference type="eggNOG" id="KOG3575">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157097"/>
<dbReference type="HOGENOM" id="CLU_007368_4_1_1"/>
<dbReference type="InParanoid" id="Q07869"/>
<dbReference type="KO" id="K07294"/>
<dbReference type="OMA" id="FSFTEYQ"/>
<dbReference type="PhylomeDB" id="Q07869"/>
<dbReference type="TreeFam" id="TF316304"/>
<dbReference type="PathwayCommons" id="Q07869"/>
<dbReference type="Reactome" id="R-HSA-1368082">
<property type="pathway name" value="RORA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1368108">
<property type="pathway name" value="BMAL1:CLOCK,NPAS2 activates circadian gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2151201">
<property type="pathway name" value="Transcriptional activation of mitochondrial biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2426168">
<property type="pathway name" value="Activation of gene expression by SREBF (SREBP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-383280">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400206">
<property type="pathway name" value="Regulation of lipid metabolism by PPARalpha"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4090294">
<property type="pathway name" value="SUMOylation of intracellular receptors"/>
</dbReference>
<dbReference type="SignaLink" id="Q07869"/>
<dbReference type="SIGNOR" id="Q07869"/>
<dbReference type="BioGRID-ORCS" id="5465">
<property type="hits" value="9 hits in 895 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PPARA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q07869"/>
<dbReference type="GeneWiki" id="Peroxisome_proliferator-activated_receptor_alpha"/>
<dbReference type="GenomeRNAi" id="5465"/>
<dbReference type="Pharos" id="Q07869">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:Q07869"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="RNAct" id="Q07869">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000186951">
<property type="expression patterns" value="Expressed in liver and 225 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q07869">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q07869">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0008144">
<property type="term" value="F:drug binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008289">
<property type="term" value="F:lipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097371">
<property type="term" value="F:MDM2/MDM4 family protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051525">
<property type="term" value="F:NFAT protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019902">
<property type="term" value="F:phosphatase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001103">
<property type="term" value="F:RNA polymerase II repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003707">
<property type="term" value="F:steroid hormone receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001223">
<property type="term" value="F:transcription coactivator binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031624">
<property type="term" value="F:ubiquitin conjugating enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0035095">
<property type="term" value="P:behavioral response to nicotine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0009267">
<property type="term" value="P:cellular response to starvation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070166">
<property type="term" value="P:enamel mineralization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008544">
<property type="term" value="P:epidermis development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006631">
<property type="term" value="P:fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0015908">
<property type="term" value="P:fatty acid transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009755">
<property type="term" value="P:hormone-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006629">
<property type="term" value="P:lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042157">
<property type="term" value="P:lipoprotein metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032099">
<property type="term" value="P:negative regulation of appetite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045776">
<property type="term" value="P:negative regulation of blood pressure"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061052">
<property type="term" value="P:negative regulation of cell growth involved in cardiac muscle cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010887">
<property type="term" value="P:negative regulation of cholesterol storage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045820">
<property type="term" value="P:negative regulation of glycolytic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903038">
<property type="term" value="P:negative regulation of leukocyte cell-cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010745">
<property type="term" value="P:negative regulation of macrophage derived foam cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902894">
<property type="term" value="P:negative regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032091">
<property type="term" value="P:negative regulation of protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010871">
<property type="term" value="P:negative regulation of receptor biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010891">
<property type="term" value="P:negative regulation of sequestering of triglyceride"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032000">
<property type="term" value="P:positive regulation of fatty acid beta-oxidation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045923">
<property type="term" value="P:positive regulation of fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046321">
<property type="term" value="P:positive regulation of fatty acid oxidation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045722">
<property type="term" value="P:positive regulation of gluconeogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010565">
<property type="term" value="P:regulation of cellular ketone metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019217">
<property type="term" value="P:regulation of fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019216">
<property type="term" value="P:regulation of lipid metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032868">
<property type="term" value="P:response to insulin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033993">
<property type="term" value="P:response to lipid"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00382"/>
<dbReference type="InterPro" id="IPR003074">
<property type="entry name" value="1Cnucl_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001723">
<property type="entry name" value="Nuclear_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003076">
<property type="entry name" value="PPAR-alpha"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01288">
<property type="entry name" value="PROXISOMEPAR"/>
</dbReference>
<dbReference type="PRINTS" id="PR01289">
<property type="entry name" value="PROXISOMPAAR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00398">
<property type="entry name" value="STRDHORMONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Peroxisome proliferator-activated receptor alpha" id="PRO_0000053481">
<location>
<begin position="1"/>
<end position="468"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="9">
<location>
<begin position="239"/>
<end position="466"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="8">
<location>
<begin position="99"/>
<end position="173"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="8">
<location>
<begin position="102"/>
<end position="122"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="8">
<location>
<begin position="139"/>
<end position="161"/>
</location>
</feature>
<feature type="region of interest" description="Required for heterodimerization with RXRA">
<location>
<begin position="304"/>
<end position="433"/>
</location>
</feature>
<feature type="binding site" description="Synthetic agonist" evidence="12 13 14 15 16">
<location>
<position position="280"/>
</location>
</feature>
<feature type="binding site" description="Synthetic agonist" evidence="12 13 14 15 16">
<location>
<position position="314"/>
</location>
</feature>
<feature type="binding site" description="Synthetic agonist" evidence="12 13 14 15 16">
<location>
<position position="440"/>
</location>
</feature>
<feature type="binding site" description="Synthetic agonist" evidence="12 13 14 15 16">
<location>
<position position="464"/>
</location>
</feature>
<feature type="site" description="Essential for heterodimerization with RXRA">
<location>
<position position="433"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047571" evidence="30">
<original>IRFG</original>
<variation>FCHT</variation>
<location>
<begin position="171"/>
<end position="174"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047572" evidence="30">
<location>
<begin position="175"/>
<end position="468"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800204." id="VAR_016110">
<original>R</original>
<variation>Q</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800206." id="VAR_016111" evidence="29">
<original>L</original>
<variation>V</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800234." id="VAR_016112">
<original>V</original>
<variation>A</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1042311." id="VAR_016113" evidence="24">
<original>A</original>
<variation>V</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800242." id="VAR_016114">
<original>D</original>
<variation>N</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229245." id="VAR_050578">
<original>G</original>
<variation>R</variation>
<location>
<position position="395"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800243." id="VAR_016115">
<original>R</original>
<variation>T</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents DNA binding but no effect on heterodimerization with RXRA." evidence="23">
<original>C</original>
<variation>G</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced heterodimerization with RXRA. Reduced DNA binding." evidence="10">
<original>D</original>
<variation>A</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes heterodimerization with RXRA. No DNA binding." evidence="10">
<original>L</original>
<variation>R</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes heterodimerization with RXRA. No DNA binding." evidence="10">
<original>L</original>
<variation>R</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on heterodimerization with RXRA nor on DNA binding and transactivation activity." evidence="23">
<original>L</original>
<variation>R</variation>
<location>
<position position="422"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on heterodimerization with RXRA nor on DNA binding." evidence="10">
<original>A</original>
<variation>T</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes heterodimerization with RXRA, DNA binding and transactivation activity." evidence="23">
<original>L</original>
<variation>R</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA68898." ref="3" evidence="31">
<original>T</original>
<variation>M</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA68898." ref="3" evidence="31">
<original>K</original>
<variation>M</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36468." ref="1" evidence="31">
<original>G</original>
<variation>A</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA68898." ref="3" evidence="31">
<original>V</original>
<variation>A</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="203"/>
<end position="217"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="222"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="233"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="239"/>
<end position="241"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="244"/>
<end position="254"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="256"/>
<end position="259"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="263"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="268"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="291"/>
<end position="293"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="295"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="302"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="329"/>
<end position="332"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="333"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="337"/>
<end position="340"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="341"/>
<end position="346"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="352"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="372"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="394"/>
<end position="415"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="422"/>
<end position="450"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="453"/>
<end position="456"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="458"/>
<end position="464"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1K7L"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KKQ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2P54"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ZNN"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VI8"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P23204"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P37230"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10195690"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10681503"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11587644"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11698662"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11845213"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17157019"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17243659"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19116277"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349176"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19622862"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21047783"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24043310"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28167758"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7629123"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7684926"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7981125"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8993548"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9238002"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9556573"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="30" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<sequence length="468" mass="52225" checksum="850846FD51ADA883" modified="1998-07-15" version="2">MVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFGFTEYQYLGSCPGSDGSVITDTLSPASSPSSVTYPVVPGSVDESPSGALNIECRICGDKASGYHYGVHACEGCKGFFRRTIRLKLVYDKCDRSCKIQKKNRNKCQYCRFHKCLSVGMSHNAIRFGRMPRSEKAKLKAEILTCEHDIEDSETADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

